Completed NA INTERVENTIONAL NCT00366925

CESA 5.10 Investigation to Compare the Efficacy and Safety of the Adacolumn® Apheresis Device in Patients With Active Ulcerative Colitis

Randomized Controlled Multicenter Investigation to Compare the Efficacy and Safety of Adacolumn® Granulocytes, Monocytes/Macrophage Apheresis Device, 5 Versus 10 Treatments, in Patients With Active Ulcerative Colitis

Sponsor: Otsuka Frankfurt Research Institute GmbH

Conditions Ulcerative Colitis

Interventions Adacolumn®

Updated 5 times since 2017 Last updated: Apr 27, 2009 Started: Apr 30, 2006 Primary completion: Feb 29, 2008 Completion: Jul 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Ulcerative Colitis, this trial is completed. The trial is conducted by Otsuka Frankfurt Research Institute GmbH and has accumulated 5 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Apr 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Otsuka Frankfurt Research Institute GmbH

Data source: Otsuka Frankfurt Research Institute GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Frankfurt am Main, Germany